Trials / Completed
CompletedNCT00432757
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic Conjunctivitis in a Population of Allergic Contact Lens Wearers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Vistakon Pharmaceuticals · Industry
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketotifen with a Contact Lens (generic name not yet established) |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-03-01
- First posted
- 2007-02-08
- Last updated
- 2009-04-09
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00432757. Inclusion in this directory is not an endorsement.